Stock CENBF CEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News CEN Biotech, Inc.

Equities

CENBF

CA15130L1040

Market Closed - OTC Markets
Other stock markets
 12:50:25 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.0031 USD 0.00% Intraday chart for CEN Biotech, Inc. 0.00% +3.33%
2023 CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer CI
2022 CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer
CI
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
AQ
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
CEN BIOTECH INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
CEN BIOTECH INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
AQ
CEN Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
CEN Biotech, Inc. announced that it has received $0.07 million in funding from 1800 Diagonal Lending, LLC
CI
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
AQ
CEN Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
CEN BIOTECH INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
AQ
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
CEN Biotech, Inc. Announces Changes to Its Board
CI
CEN BIOTECH INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
CEN Biotech, Inc. Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CENBF Stock
  4. News CEN Biotech, Inc.